The startup provides stem cell therapy services targeting autoimmune and degenerative diseases through specialized treatments and topical applications. By offering affordable therapies for conditions such as Alzheimer's, diabetes, and orthopedic injuries, the company enhances patient access to regenerative medicine solutions.
Funding
$5.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals suffering from autoimmune diseases, orthopedic injuries, and degenerative conditions face limited treatment options that effectively promote healing, reduce inflammation, and regenerate damaged tissues. Traditional treatments often fall short in providing long-term relief and can involve invasive procedures or ineffective medications.
Solution
BioXcellerator provides advanced stem cell therapy and regenerative medicine solutions designed to alleviate suffering and improve the quality of life for patients with a wide range of conditions. The company utilizes mesenchymal stem cells (MSCs) derived from Wharton’s Jelly umbilical cord tissue, selected for their high potential to stimulate healing. These Signature Cells undergo a proprietary process to ensure high potency and purity, demonstrating high levels of anti-inflammatory properties and the potential to modulate the immune system. BioXcellerator's personalized treatment plans are developed by medical specialists based on individual health needs, aiming to create an optimal environment for the body to heal itself, reduce inflammation, and regenerate damaged tissues.
Target Audience
The primary target audience includes individuals suffering from autoimmune diseases, chronic pain, neurological conditions, orthopedic and sports injuries, spine and disc conditions, and other degenerative disorders seeking advanced regenerative medicine solutions.
Features
- Proprietary Signature Cells process using MSCs derived from Wharton’s Jelly umbilical cord tissue
- High-potency cells cultured and expanded under strict quality control protocols
- Cells tested for specific markers indicating anti-inflammatory properties and immune modulation potential
- Personalized treatment plans developed by medical specialists
- On-site lab and cell bank facilities meeting international quality standards
- GMP standards (Good manufacturing practices)
- FACT-JACIE International standards for the collection, processing, and administration of hematopoietic stem cell therapy products